Patents Represented by Attorney Virginia Meyer
  • Patent number: 4937191
    Abstract: A method producing a non-heme haloperoxidase which is substantially resistant to inactivation, at room temperature, in up to 0.3M H.sub.2 O.sub.2 for up to 25 hours, and up to 0.5mM HOCl for up to two minutes. One such haloperoxidase, isolated from Curvularia inaequalis, contains about 2 gram atoms of zinc per molecule. A halogenation reaction employing the enzyme can be performed at H.sub.2 O.sub.2 and hypohalous acid concentrations which produce rapid inactivation of heme-containing haloperoxidases.
    Type: Grant
    Filed: November 12, 1987
    Date of Patent: June 26, 1990
    Assignee: Cetus Corporation
    Inventors: John Geigert, Te-Ning E. Liu, Thabiso N'timkulu
  • Patent number: 4937192
    Abstract: A halogenation method using a haloperoxidase obtained from a fungus selected from the dematiaceous hyphomycetes. The enzyme has an optimum activity above about pH 5.0, and can oxidize chloride, bromide, or iodide ions.
    Type: Grant
    Filed: November 12, 1987
    Date of Patent: June 26, 1990
    Assignee: Cetus Corporation
    Inventors: Jennie C. Hunter, Angela Belt, Lynn S. Sotos, Michelle E. Fonda
  • Patent number: 4711843
    Abstract: A method and a cloning vector are described for the controlled accumulation of cloned heterologous gene products in Bacillus subtilis. The cloning vector is capable of being replicated in B. subtilis and includes the heterologous gene located and oriented such as to be under the control of an operator, promoter, and ribosomal binding site sequence. The gene codes for a protein which is under the control of a transport mechanism by which the protein is secreted by the B. subtilis. The gene product is recovered from the growth medium for the B. subtilis. The cloning vector is also capable of similar use in other bacteria such as E. coli.
    Type: Grant
    Filed: January 26, 1983
    Date of Patent: December 8, 1987
    Assignee: Cetus Corporation
    Inventor: Shing Chang
  • Patent number: 4711844
    Abstract: The invention discloses a method for producing modified signal peptides sequences derived from wild-type signal peptide sequences of the type that are capable of forming membrane-bound lipoproteins. Modified signal peptide sequences produced by the method of the invention are useful for increasing the secretion of heterologous gene products produced by transformed host organisms. The invention further discloses a method for producing recombinant DNA sequences in vivo.
    Type: Grant
    Filed: March 9, 1983
    Date of Patent: December 8, 1987
    Assignee: Cetus Corporation
    Inventor: Shing Chang
  • Patent number: 4707447
    Abstract: A halogenation method using a haloperoxidase obtained from a fungus selected from the dematiaceous hyphomycetes. The enzyme has an optimum activity above about pH 5.0, and can oxidize chloride, bromide, or iodide ions.
    Type: Grant
    Filed: May 24, 1983
    Date of Patent: November 17, 1987
    Assignee: Cetus Corporation
    Inventors: Jennie C. Hunter, Angela Belt, Lynn S. Sotos, Michelle E. Fonda
  • Patent number: 4707446
    Abstract: A method of producing a non-heme haloperoxidase which is substantially resistant to inactivation, at room temperature, in up to 0.3M H.sub.2 O.sub.2 for up to 25 hours, and up to 0.5 mM HOCl for up to two minutes. One such haloperoxidase, isolated from Curvularia inaequalis, contains about 2 gram atoms of zinc per molecule. A halogenation reaction employing the enzyme can be performed at H.sub.2 O.sub.2 and hypohalous acid concentrations which produce rapid inactivation of heme-containing haloperoxidases.
    Type: Grant
    Filed: May 24, 1983
    Date of Patent: November 17, 1987
    Assignee: Cetus Corporation
    Inventors: John Geigert, Te-Ning E. Liu, Thabiso N'timkulu
  • Patent number: 4631257
    Abstract: DNA plasmids are described which are selected mutants in which an altered repressor gene leads to high copy number replication. Elements in the plasmids are modified in such a way that readthrough expression of heterologous DNA inserted in the plasmid will not continue into the replication primer strand. Deletions resulting from interference with replication primer strand transcription are thereby avoided.
    Type: Grant
    Filed: February 17, 1983
    Date of Patent: December 23, 1986
    Assignee: Cetus Corporation
    Inventor: David H. Gelfand